This Is What Whales Are Betting On DexCom
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bullish stance on DexCom (NASDAQ:DXCM), with 64% of investors opening trades with bullish expectations. The whale has been targeting a price range from $60.0 to $150.0 for DexCom over the last 3 months. JP Morgan, Morgan Stanley, and Stifel have maintained their positive ratings on DexCom, while Leerink Partners downgraded its action to Outperform.
October 26, 2023 | 7:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
A whale investor has taken a bullish stance on DexCom, with a majority of investors also showing bullish expectations. Analysts from JP Morgan, Morgan Stanley, and Stifel have maintained their positive ratings, while Leerink Partners has downgraded its rating to Outperform.
The bullish stance of a whale investor, along with the majority of traders, indicates a positive sentiment towards DexCom. This, combined with the positive ratings from major analysts, suggests a potential increase in DexCom's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100